Leyao Tang , Ziling Feng , Wenqi Liu , Wenyan Zhang , Yamin Liu , Ni Xiong , Wenhang Chen , Xin Yin Wu , Jianzhou Yang , Wenjie Dai
{"title":"痴呆患者死亡率的危险因素:系统回顾和荟萃分析","authors":"Leyao Tang , Ziling Feng , Wenqi Liu , Wenyan Zhang , Yamin Liu , Ni Xiong , Wenhang Chen , Xin Yin Wu , Jianzhou Yang , Wenjie Dai","doi":"10.1016/j.archger.2025.105951","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Individuals with dementia had an increased risk of mortality. This systematic review aimed to comprehensively update current evidence on risk factors for mortality in individuals with dementia.</div></div><div><h3>Methods</h3><div>A database search of PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, and Chinese Scientific Journals Full-text Database was conducted from inception until October 2024. The effect size was expressed as a pooled hazard ratio (HR) and 95 % confidence interval (CI). The heterogeneity was analyzed by Cochran’s <em>Q</em> test and the <em>I<sup>2</sup></em> statistic.</div></div><div><h3>Results</h3><div>Thirty-three eligible studies with 21 factors were included. The results showed that the risk factors for mortality in individuals with dementia were advanced age at survey (HR = 1.05, 95 % CI: 1.03–1.07), advanced age at dementia symptom onset (HR = 1.05, 95 % CI: 1.03–1.07), male sex (HR = 1.58, 95 % CI: 1.49–1.68), hypertension (HR = 1.21, 95 % CI: 1.09–1.34), diabetes (HR = 1.30, 95 % CI: 1.09–1.56), cerebrovascular disease (HR = 1.08, 95 % CI: 1.00–1.18), lung disease (HR = 1.57, 95 % CI: 1.00–2.47), higher CCI score (HR = 1.11, 95 % CI: 1.00–1.22), and higher CDR score (HR = 1.47, 95 % CI: 1.02–2.13). Non-whites (HR = 0.68, 95 % CI: 0.63–0.73), and those with depression (HR = 0.88, 95 % CI: 0.79–0.98), dyslipidemia (HR = 0.77, 95 % CI: 0.69–0.85), treatment with AChEIs (HR = 0.73, 95 % CI: 0.66–0.81), and higher MMSE score (HR = 0.95, 95 % CI: 0.94–0.97) had a lower risk.</div></div><div><h3>Conclusions</h3><div>Age at survey, age at dementia symptom onset, sex, race, hypertension, diabetes, dyslipidemia, depression, cerebrovascular disease, lung disease, CCI, AChEIs, MMSE, and CDR were associated with mortality in individuals with dementia.</div></div>","PeriodicalId":8306,"journal":{"name":"Archives of gerontology and geriatrics","volume":"137 ","pages":"Article 105951"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk factors for mortality in individuals with dementia: a systematic review and meta-analysis\",\"authors\":\"Leyao Tang , Ziling Feng , Wenqi Liu , Wenyan Zhang , Yamin Liu , Ni Xiong , Wenhang Chen , Xin Yin Wu , Jianzhou Yang , Wenjie Dai\",\"doi\":\"10.1016/j.archger.2025.105951\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Individuals with dementia had an increased risk of mortality. This systematic review aimed to comprehensively update current evidence on risk factors for mortality in individuals with dementia.</div></div><div><h3>Methods</h3><div>A database search of PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, and Chinese Scientific Journals Full-text Database was conducted from inception until October 2024. The effect size was expressed as a pooled hazard ratio (HR) and 95 % confidence interval (CI). The heterogeneity was analyzed by Cochran’s <em>Q</em> test and the <em>I<sup>2</sup></em> statistic.</div></div><div><h3>Results</h3><div>Thirty-three eligible studies with 21 factors were included. The results showed that the risk factors for mortality in individuals with dementia were advanced age at survey (HR = 1.05, 95 % CI: 1.03–1.07), advanced age at dementia symptom onset (HR = 1.05, 95 % CI: 1.03–1.07), male sex (HR = 1.58, 95 % CI: 1.49–1.68), hypertension (HR = 1.21, 95 % CI: 1.09–1.34), diabetes (HR = 1.30, 95 % CI: 1.09–1.56), cerebrovascular disease (HR = 1.08, 95 % CI: 1.00–1.18), lung disease (HR = 1.57, 95 % CI: 1.00–2.47), higher CCI score (HR = 1.11, 95 % CI: 1.00–1.22), and higher CDR score (HR = 1.47, 95 % CI: 1.02–2.13). Non-whites (HR = 0.68, 95 % CI: 0.63–0.73), and those with depression (HR = 0.88, 95 % CI: 0.79–0.98), dyslipidemia (HR = 0.77, 95 % CI: 0.69–0.85), treatment with AChEIs (HR = 0.73, 95 % CI: 0.66–0.81), and higher MMSE score (HR = 0.95, 95 % CI: 0.94–0.97) had a lower risk.</div></div><div><h3>Conclusions</h3><div>Age at survey, age at dementia symptom onset, sex, race, hypertension, diabetes, dyslipidemia, depression, cerebrovascular disease, lung disease, CCI, AChEIs, MMSE, and CDR were associated with mortality in individuals with dementia.</div></div>\",\"PeriodicalId\":8306,\"journal\":{\"name\":\"Archives of gerontology and geriatrics\",\"volume\":\"137 \",\"pages\":\"Article 105951\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of gerontology and geriatrics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0167494325002080\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of gerontology and geriatrics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167494325002080","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Risk factors for mortality in individuals with dementia: a systematic review and meta-analysis
Background
Individuals with dementia had an increased risk of mortality. This systematic review aimed to comprehensively update current evidence on risk factors for mortality in individuals with dementia.
Methods
A database search of PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, and Chinese Scientific Journals Full-text Database was conducted from inception until October 2024. The effect size was expressed as a pooled hazard ratio (HR) and 95 % confidence interval (CI). The heterogeneity was analyzed by Cochran’s Q test and the I2 statistic.
Results
Thirty-three eligible studies with 21 factors were included. The results showed that the risk factors for mortality in individuals with dementia were advanced age at survey (HR = 1.05, 95 % CI: 1.03–1.07), advanced age at dementia symptom onset (HR = 1.05, 95 % CI: 1.03–1.07), male sex (HR = 1.58, 95 % CI: 1.49–1.68), hypertension (HR = 1.21, 95 % CI: 1.09–1.34), diabetes (HR = 1.30, 95 % CI: 1.09–1.56), cerebrovascular disease (HR = 1.08, 95 % CI: 1.00–1.18), lung disease (HR = 1.57, 95 % CI: 1.00–2.47), higher CCI score (HR = 1.11, 95 % CI: 1.00–1.22), and higher CDR score (HR = 1.47, 95 % CI: 1.02–2.13). Non-whites (HR = 0.68, 95 % CI: 0.63–0.73), and those with depression (HR = 0.88, 95 % CI: 0.79–0.98), dyslipidemia (HR = 0.77, 95 % CI: 0.69–0.85), treatment with AChEIs (HR = 0.73, 95 % CI: 0.66–0.81), and higher MMSE score (HR = 0.95, 95 % CI: 0.94–0.97) had a lower risk.
Conclusions
Age at survey, age at dementia symptom onset, sex, race, hypertension, diabetes, dyslipidemia, depression, cerebrovascular disease, lung disease, CCI, AChEIs, MMSE, and CDR were associated with mortality in individuals with dementia.
期刊介绍:
Archives of Gerontology and Geriatrics provides a medium for the publication of papers from the fields of experimental gerontology and clinical and social geriatrics. The principal aim of the journal is to facilitate the exchange of information between specialists in these three fields of gerontological research. Experimental papers dealing with the basic mechanisms of aging at molecular, cellular, tissue or organ levels will be published.
Clinical papers will be accepted if they provide sufficiently new information or are of fundamental importance for the knowledge of human aging. Purely descriptive clinical papers will be accepted only if the results permit further interpretation. Papers dealing with anti-aging pharmacological preparations in humans are welcome. Papers on the social aspects of geriatrics will be accepted if they are of general interest regarding the epidemiology of aging and the efficiency and working methods of the social organizations for the health care of the elderly.